We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.02B
AUM Growth
+$74.7M
Cap. Flow
-$986K
Cap. Flow %
-0.1%
Top 10 Hldgs %
31.61%
Holding
254
New
10
Increased
66
Reduced
77
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.43M
2
QCOM icon
Qualcomm
QCOM
+$1.65M
3
BX icon
Blackstone
BX
+$1.52M
4
DIS icon
Walt Disney
DIS
+$869K
5
ZTS icon
Zoetis
ZTS
+$790K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.24M
2
BA icon
Boeing
BA
+$1.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$1.35M
4
XOM icon
ExxonMobil
XOM
+$1.3M
5
AGN
Allergan plc
AGN
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 20.13%
2 Technology 16.35%
3 Financials 15.15%
4 Industrials 12.69%
5 Energy 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTN
176
DELISTED
Raytheon Company
RTN
$366K 0.04%
1,664
– –
AMGN icon
177
Amgen
AMGN
$222B
$356K 0.03%
1,477
– –
BDX icon
178
Becton Dickinson
BDX
$48.2B
$344K 0.03%
1,296
– –
MNDT
179
DELISTED
Mandiant, Inc. Common Stock
MNDT
$331K 0.03%
20,025
-15,675
-44% -$251K
STT icon
180
State Street
STT
$50.7B
$328K 0.03%
4,150
– –
INTU icon
181
Intuit
INTU
$89B
$316K 0.03%
1,207
– –
HES
182
DELISTED
Hess
HES
$308K 0.03%
4,612
– –
LHX icon
183
L3Harris
LHX
$53.4B
$305K 0.03%
1,542
-138
-8% -$27.7K
ADM icon
184
Archer Daniels Midland
ADM
$36.9B
$301K 0.03%
6,500
– –
PBCT
185
DELISTED
People's United Financial Inc
PBCT
$301K 0.03%
17,791
– –
L icon
186
Loews
L
$23.6B
$298K 0.03%
5,670
– –
ACGL icon
187
Arch Capital
ACGL
$33.6B
$297K 0.03%
6,930
– –
D icon
188
Dominion Energy
D
$59.3B
$297K 0.03%
3,590
-146
-4% -$11.9K
AWK icon
189
American Water Works
AWK
$26.9B
$295K 0.03%
2,400
– –
C icon
190
Citigroup
C
$226B
$295K 0.03%
+3,702
New +$274K
PAA icon
191
Plains All American Pipeline
PAA
$16.1B
$295K 0.03%
16,014
-600
-4% -$11K
BMY.RT
192
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$278K 0.03%
+92,409
New +$240K
GIS icon
193
General Mills
GIS
$19.7B
$274K 0.03%
5,114
– –
ORI icon
194
Old Republic International
ORI
$10.4B
$262K 0.03%
11,720
– –
AVGO icon
195
Broadcom
AVGO
$2.04T
$253K 0.02%
8,000
– –
PEG icon
196
Public Service Enterprise Group
PEG
$37.7B
$253K 0.02%
4,284
– –
TRV icon
197
Travelers Companies
TRV
$80.2B
$253K 0.02%
1,850
– –
FCX icon
198
Freeport-McMoran
FCX
$97.5B
$249K 0.02%
19,009
– –
SBUX icon
199
Starbucks
SBUX
$120B
$230K 0.02%
2,616
– –
AON icon
200
Aon
AON
$76B
$229K 0.02%
1,100
– –
5 6 7
8
9

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2019 Portfolio in Review

As of Q4 2019, Neville Rodie & Shaw held 254 positions worth $1.02B, up 7.9% from $945M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Neville Rodie & Shaw's Q4 2019 filing shows 10 new, 66 increased, 77 reduced and 4 closed positions. Its largest new stake was Qualcomm: 19,730 shares worth $1.74M. The largest sale was Celgene Corp, an estimated $9.24M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • Neville Rodie & Shaw's largest Q4 2019 buy was Qualcomm: 19,730 shares worth $1.74M.
  • Neville Rodie & Shaw added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.43M increase.
  • Neville Rodie & Shaw's biggest Q4 2019 reduction was Boeing, cutting an estimated $1.45M.
  • Neville Rodie & Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $9.24M.
  • Neville Rodie & Shaw's ten largest holdings make up 32% of its $1.02B portfolio in Q4 2019.
  • Neville Rodie & Shaw opened 10 new positions and closed 4 in Q4 2019.
  • Neville Rodie & Shaw's portfolio value rose 7.9% quarter-over-quarter to $1.02B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2019, filed 8 Jan 2020.